NEW SPARKLEROLL (00970) plans to issue a total of 112.6 million shares at a discount of about 13.64%, with a net raise of approximately HK$41.67 million.
New Ray Development (00970) announced that on January 16, 2026, the company plans to issue a total of 112.6 million shares to the subscribers (Holy Mark Industrial Development Co., Ltd., Mr. Liu Junjian, Ms. Zheng Yongshi, Mr. Li Zhancheng), equivalent to approximately 16.67% of the total number of issued shares after the completion of the issuance.
NEW SPARKLEROLL (00970) announces that on January 16, 2026, the company plans to issue a total of 112.6 million shares to the subscribers (Saint Wei Industrial Development Limited, Mr. Liu Junjian, Ms. Zheng Yongshi, Mr. Li Zhancheng), equivalent to approximately 16.67% of the total issued shares after the completion of the issuance. The subscription price for the shares is HK$0.380 per share, representing a discount of approximately 13.64% from the closing price of HK$0.440 per share on January 16. The total proceeds from the subscription will be approximately HK$42.77 million, and the net proceeds will be approximately HK$41.67 million. The company plans to use approximately HK$30 million of the net proceeds for the expansion and development of the group's automotive distribution business, and approximately HK$11.67 million for potential investments when opportunities arise.
Related Articles

Linzhou Heavy Machinery Group (002535.SZ) terminates the matter of non-publicly issuing shares in 2025.

Haisco Pharmaceutical Group (002653.SZ) has obtained two indications for the innovative drug HSK44459 cream, with IND applications accepted.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.
Linzhou Heavy Machinery Group (002535.SZ) terminates the matter of non-publicly issuing shares in 2025.

Haisco Pharmaceutical Group (002653.SZ) has obtained two indications for the innovative drug HSK44459 cream, with IND applications accepted.

Haisco Pharmaceutical Group (002653.SZ): Innovative drug HSK31679 tablet included in breakthrough therapy program.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


